Presented by the Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of Tuberculosis Elimination (DTBE), Laboratory Branch (LB), in collaboration with the Georgia Department of Public Health, Public Health Laboratory (GA PHL).
DESCRIPTION
This workshop will further educate participants on diagnostic Mycobacterium tuberculosis complex (MTBC) principles and procedures. Lectures, hands-on laboratory exercises, group discussions and interactive sessions will be used to increase knowledge. State-of-the-art diagnostic molecular and growth-based methods for detection, isolation, identification (ID) and drug susceptibility testing (DST) of MTBC will be discussed and compared. Attendees will be provided with the tools necessary to determine appropriate safety practices and testing algorithms. Case studies will highlight interesting tuberculosis case results including the importance of accurate result interpretation, collaboration with TB Programs and other laboratories, lessons learned and problem-solving. Attendees are expected to present case studies and to participate in group discussions by describing testing algorithms/methods.
AUDIENCE
This workshop is intended for laboratory professionals with a minimum of one year of experience in a laboratory that identifies MTBC and performs detection, isolation, ID, and DST with preference given to laboratory professionals working in public health laboratories.
OBJECTIVES
At the conclusion of the program, the participant will be able to:
- Discuss important risk assessment considerations for the mycobacteriology laboratory
- Identify appropriate biosafety practices for the mycobacteriology laboratory work
- Compare and contrast test methods for processing, AFB smear, culture and ID, growth-based DST and molecular detection of MTBC
- Describe mutations associated with drug resistance for MTBC and common correlations between mutations and growth-based results
- Discuss mycobacteriology case studies related to testing algorithms and interpretation of results
- Explain the importance of assessing laboratory-specific data and quality performance measures for the mycobacteriology laboratory
- Recognize accepted validation methods
- Describe next generation sequencing (NGS) and its potential use in the mycobacteriology laboratory
FACULTY
Division of Tuberculosis Elimination (DTBE), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, Atlanta, GA
Scott Burns, MS, Biologist
Lauren Cowan, PhD, Microbiologist
Melinda Dunn, PhD, Safety Officer
Pei-Jean Feng, MPH, Epidemiologist
Stephanie Johnston, MS, Team Lead
Danielle Miller, BS, Quality Manager
Janná Murray, MS, MPH, Biologist
Jamie Posey, PhD, Team Lead
David Sikes, BS, MT(ASCP), Microbiologist
Cortney Stafford, MPH, MT(ASCP), Laboratory Consultant
Angela Starks, PhD, Branch Chief
Stephanie Swint, MPH, MLS(AMT), Laboratory Consultant
Sarah Talarico, PhD, Epidemiologist
Jonathan Wortham, MD, Medical Officer
Monica Youngblood, MPH, M(ASCP), Laboratory Consultant
Alaska Division of Public Health, State Public Health Laboratories, Anchorage, AK
Yvette Vergnetti, MS MLSL, MT/MLS (ASCP), TB Technical Supervisor
Georgia Department of Public Health, Atlanta, GA
Lauren Miller, MPH, Epidemiologist II
Georgia Public Health Laboratory, Decatur, GA
Blake Bertrand, PhD, MB(ASCP), Sequencing Manager
Jean Patel, PhD, D(ABMM), Microbiology Service Director
Kelsie Pasley, BS, MB(ASCP), Mycobacteriology Manager
Michigan Department of Health and Human Services, Lansing, MI
Jolene Vanneste, BS, Mycobacteriology Unit Senior Microbiologist
Oregon State Public Health Laboratory, Hillsboro, OR
Mackenzie Clary, MLS(ASCP)CM, Microbiologist III
Virginia Division of Consolidated Laboratory Services, Richmond, VA
Kathleen Milloy, MS, MLS(ASCP), Principal Scientist
TRAVEL
- All travel and logistical details will be provided upon acceptance into the workshop.
- Some states have lengthy travel approval processes so it is important to begin the process as soon as possible. However, DO NOT make any travel arrangements until you are notified of acceptance into the workshop.
- Participants are responsible for all lodging, meals and travel costs.
- A group lodging discount is being negotiated at the current federal per diem rate (plus tax and fees) per night.
- A limited number of travel scholarships will be available for accepted participants.
- Transportation between the hotel and GA PHL will be provided.
ACCESSIBILITY
In compliance with the Americans with Disabilities Act, individuals seeking special accommodations must email a request to Ashton Blair (ashton.blair@aphl.org) at least three weeks prior to the workshop’s start date.
CREATE AN ACCOUNT WITH APHL!
If you do not have an account with us, you will need to create an account before attempting to register. Through your account portal you will be able to track your events, invoices, transactions and much more!
If you already have an account, make sure you login before registering!
Contact admin.sp@aphl.org with any login or account questions. Review this guide for help with the registration process.
REGISTRATION CONSENT
By registering for this event, you are consenting to have your information shared with APHL event stakeholders, such as the Centers for Disease Control and Prevention and Public Health Labs. We will not, in any circumstances, share your information with other individuals or organizations without your permission, including corporations or individuals, except when applicable by law. We do not sell, communicate or divulge your information to any mailing lists.